Access cutting-edge age-related macular degeneration treatment through this clinical trial at a research site in Springdale. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Springdale location
Access age-related macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related age-related macular degeneration treatment provided free
Check if you qualify for this age-related macular degeneration clinical trial in Springdale, AR
No-Cost Study Care
Local to Springdale
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of AMD which is an eye condition affecting central vision (what one sees straight ahead). The purpose of this study is to evaluate the progression rate of Geographic Atrophy in eyes of patients treated with cemdisiran alone
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT06541704) has an active research site in Springdale, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for age-related macular degeneration treatment options in Springdale, AR, this clinical trial (NCT06541704) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all age-related macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Springdale — not just this study.
Browse Rheumatoid Arthritis Trials in Springdale →